Attached files

file filename
10-K - FORM 10-K - IMMUNOMEDICS INCd10k.htm
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) - IMMUNOMEDICS INCdex311.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ERNST & YOUNG LLP - IMMUNOMEDICS INCdex231.htm
EX-31.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) - IMMUNOMEDICS INCdex312.htm
EX-10.35 - SIXTH AMENDMENT EXTENSION AGREEMENT DATED FEBRUARY 11, 2011 - IMMUNOMEDICS INCdex1035.htm
EX-32.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 - IMMUNOMEDICS INCdex322.htm
EX-32.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 - IMMUNOMEDICS INCdex321.htm

EXHIBIT 21.1

SUBSIDIARIES OF THE COMPANY AS OF JUNE 30, 2011

 

•      Immunomedics, B.V. (Netherlands)

  Wholly owned subsidiary of Immunomedics, Inc.

•      Immunomedics GmbH (Germany)

  Wholly owned subsidiary of Immunomedics, Inc.

•      IBC Pharmaceuticals, Inc. (Delaware)

  Majority owned subsidiary of Immunomedics, Inc.